---
title: "Astrazeneca will invest $2 billion in its facility in Maryland, USA"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/266984675.md"
description: "Astrazeneca announced that it will invest $2 billion in Frederick, Maryland, to expand its biopharmaceutical manufacturing facility and build new R&D and clinical trial facilities in Gaithersburg. This investment will support 2,600 jobs and enhance the resilience of the U.S. drug supply chain"
datetime: "2025-11-21T21:37:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266984675.md)
  - [en](https://longbridge.com/en/news/266984675.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266984675.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/266984675.md) | [繁體中文](https://longbridge.com/zh-HK/news/266984675.md)


# Astrazeneca will invest $2 billion in its facility in Maryland, USA

Astrazeneca (AZN.US) announced on Friday that it will invest $2 billion in its facilities located in Maryland, USA, to build new production capacity aimed at accelerating the production of drugs for cancer, rare diseases, and chronic conditions.

The investment includes the expansion of its flagship biopharmaceutical manufacturing facility in Frederick, as well as the construction of a new facility in Gaithersburg for the research and clinical trial supply of innovative molecular drugs. The company stated that by 2029, this investment will support 2,600 jobs in the state, including construction positions and 300 high-skilled jobs.

CEO Pascal Soirot stated that this investment enhances the resilience of the U.S. drug supply chain and accelerates access to transformative therapies for patients globally and across the United States

### Related Stocks

- [AstraZeneca PLC (AZN.US)](https://longbridge.com/en/quote/AZN.US.md)

## Related News & Research

- [AstraZeneca says Efzimfotase alfa PH3 program show positive results](https://longbridge.com/en/news/281138062.md)
- [If You Invested $1000 In AstraZeneca Stock 10 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/281048213.md)
- [AstraZeneca COPD Breakthrough With Tozorakimab Adds Fresh Upside Question](https://longbridge.com/en/news/280851586.md)
- [AstraZeneca's Efzimfotase Alfa Shows Improved Bone Health in Late-stage Clinical Trials](https://longbridge.com/en/news/281136189.md)
- [AstraZeneca hails positive results in tozorakimab lung disease trials](https://longbridge.com/en/news/280752841.md)